Search research articles
Contact Us
Filters
Showing results (51-60 of 140) with videos related to
Page
of 14
Sort By:
Cancer Research
|
April 6, 2007
Systematic urokinase-activated anthrax toxin therapy produces regressions of subcutaneous human non-small cell lung tumor in athymic nude mice
Yunpeng Su, Janelle Ortiz, Shihui Liu, et al.
The American Journal of Pathology
|
September 1, 2009
Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway
Karin List, Peter Kosa, Roman Szabo, et al.
The Journal of Cell Biology
|
November 26, 2003
Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1
Karin List, Roman Szabo, Philip W Wertz, et al.
Blood
|
April 27, 2016
Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling
Sylvain M Le Gall, Roman Szabo, Melody Lee, et al.
Thrombosis and Haemostasis
|
April 21, 2005
Amalfi to Washington D. C.--twenty years of plasminogen activator research
Toni M Antalis, Thomas H Bugge, Daniel A Lawrence, et al.
The Journal of Biological Chemistry
|
April 8, 2014
The membrane-anchored serine protease prostasin (CAP1/PRSS8) supports epidermal development and postnatal homeostasis independent of its enzymatic activity
Diane E Peters, Roman Szabo, Stine Friis, et al.
The Journal of Biological Chemistry
|
August 23, 2002
Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity
Sarah Netzel-Arnett, David J Mitola, Susan S Yamada, et al.
BMC Biology
|
June 3, 2017
Matriptase zymogen supports epithelial development, homeostasis and regeneration
Stine Friis, Daniel Tadeo, Sylvain M Le-Gall, et al.
The Journal of Biological Chemistry
|
May 16, 2013
A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation
Stine Friis, Katiuchia Uzzun Sales, Sine Godiksen, et al.
Toxicology and Applied Pharmacology
|
June 28, 2014
Comparative toxicity and efficacy of engineered anthrax lethal toxin variants with broad anti-tumor activities
Diane E Peters, Benjamin Hoover, Loretta Grey Cloud, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 140) with videos related to
Sort By:
Page
of 14
Cancer Research
|
April 6, 2007
Systematic urokinase-activated anthrax toxin therapy produces regressions of subcutaneous human non-small cell lung tumor in athymic nude mice
Yunpeng Su, Janelle Ortiz, Shihui Liu, et al.
The American Journal of Pathology
|
September 1, 2009
Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway
Karin List, Peter Kosa, Roman Szabo, et al.
The Journal of Cell Biology
|
November 26, 2003
Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1
Karin List, Roman Szabo, Philip W Wertz, et al.
Blood
|
April 27, 2016
Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling
Sylvain M Le Gall, Roman Szabo, Melody Lee, et al.
Thrombosis and Haemostasis
|
April 21, 2005
Amalfi to Washington D. C.--twenty years of plasminogen activator research
Toni M Antalis, Thomas H Bugge, Daniel A Lawrence, et al.
The Journal of Biological Chemistry
|
April 8, 2014
The membrane-anchored serine protease prostasin (CAP1/PRSS8) supports epidermal development and postnatal homeostasis independent of its enzymatic activity
Diane E Peters, Roman Szabo, Stine Friis, et al.
The Journal of Biological Chemistry
|
August 23, 2002
Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity
Sarah Netzel-Arnett, David J Mitola, Susan S Yamada, et al.
BMC Biology
|
June 3, 2017
Matriptase zymogen supports epithelial development, homeostasis and regeneration
Stine Friis, Daniel Tadeo, Sylvain M Le-Gall, et al.
The Journal of Biological Chemistry
|
May 16, 2013
A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation
Stine Friis, Katiuchia Uzzun Sales, Sine Godiksen, et al.
Toxicology and Applied Pharmacology
|
June 28, 2014
Comparative toxicity and efficacy of engineered anthrax lethal toxin variants with broad anti-tumor activities
Diane E Peters, Benjamin Hoover, Loretta Grey Cloud, et al.
Page
of 14